What is the latest status of the project “North Carolina Drug Manufacturing Facility”?

The status recorded for “North Carolina Drug Manufacturing Facility” is Planned.

What is the budget and commercial profile for the project “North Carolina Drug Manufacturing Facility”?

Taiyo normalizes the budget of “North Carolina Drug Manufacturing Facility” to USD 700000000.

Where can I verify the source and access all details for “North Carolina Drug Manufacturing Facility”?

This Taiyo project page references BioSpace along with the original URL (https://www.biospace.com/business/roches-genentech-earmarks-700m-for-north-carolina-plant-as-billion-dollar-us-pledge-hangs-in-balance). Taiyo standardizes official data into a consistent, searchable project profile.

North Carolina Drug Manufacturing Facility

One of 10,000+ projects Taiyo tracks in North Carolina.

Source: BioSpace

Project

Planned

Roche and its subsidiary Genentech are investing $700 million to construct a new drug manufacturing facility in North Carolina, focused on producing next-generation obesity medicines. The facility is planned to cover 600,000 square feet and is expected to create over 400 high-wage manufacturing jobs, along with 1,500 jobs during construction and site development.

Status: Prospective
Sector: Manufacturing (Industrial), Commercial
Location: North Carolina, United States of America
Updated: 22 Jul 2026
Source: BioSpace

ConstructChat

Ask ConstructChat about North Carolina Drug Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information

4 Q

The project “North Carolina Drug Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in North Carolina, United States. Taiyo aggregates data on it from BioSpace.

Participants

Not available for this record.

Status

Original status	Planned
Taiyo status	Prospective
Taiyo last update	2026-07-22

Contact

Not available for this record.

Description

Description	Roche and its subsidiary Genentech are investing $700 million to construct a new drug manufacturing facility in North Carolina, focused on producing next-generation obesity medicines. The facility is planned to cover 600,000 square feet and is expected to create over 400 high-wage manufacturing jobs, along with 1,500 jobs during construction and site development.
Budget

Location

Country	United States of America (USA)
State	North Carolina

Source

Source	BioSpace
URL

More Details

Record type	Project
Sector	Manufacturing (Industrial), Commercial
Article published date	2025-05-16

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

Every detail on this project
News and media coverage
Technical research

View all details

Free account · no card · lands you back on this project

North Carolina Drug Manufacturing Facility

Ask ConstructChat about North Carolina Drug Manufacturing Facility

Project Information FAQ

Project Information

Research

View all details

More Manufacturing (Industrial) projects in United States